Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00936065
What this trial is testing

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
Pfizer 60
Not applicableActive Not RecruitingNCT06142357
What this trial is testing

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 199
Post-approval studies (Phase 4)UnknownNCT03307447
What this trial is testing

Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).

Who this might be right for
Psoriasis Vulgaris
Narrows Institute for Biomedical Research 30
Testing effectiveness (Phase 2)Study completedNCT06061471
What this trial is testing

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisSkin Diseases
Akeso 454
Very early researchLooking for participantsNCT07337434
What this trial is testing

To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

Who this might be right for
Chronic Plaque Psoriasis
Syeda Sana Zaman 106
Early research (Phase 1)Study completedNCT01276847
What this trial is testing

Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 40
Not applicableStudy completedNCT03511755
What this trial is testing

12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN

Who this might be right for
PsoriasisStress
Thync Global, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT02576678
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 42
Not applicableStudy completedNCT00769184
What this trial is testing

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

Who this might be right for
Psoriasis
NeoStrata Company, Inc. 15
Large-scale testing (Phase 3)UnknownNCT06477237
What this trial is testing

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Huabo Biopharm Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT04123795
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis
UCB Biopharma SRL 49
Not applicableStudy completedNCT01435265
What this trial is testing

Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab

Who this might be right for
Psoriasis
Wake Forest University Health Sciences 7
Early research (Phase 1)Study completedNCT03733353
What this trial is testing

EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
Evelo Biosciences, Inc. 204
Large-scale testing (Phase 3)Study completedNCT02698475
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Study completedNCT04453137
What this trial is testing

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alvotech Swiss AG 567
Testing effectiveness (Phase 2)Study completedNCT01132612
What this trial is testing

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 275
Testing effectiveness (Phase 2)Study completedNCT04603027
What this trial is testing

Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Psoriasis
Evelo Biosciences, Inc. 249
Early research (Phase 1)Study completedNCT05453942
What this trial is testing

Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis

Who this might be right for
Psoriasis
Sanofi 38
Large-scale testing (Phase 3)Study completedNCT02714322
What this trial is testing

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Who this might be right for
PsoriasisArthritis, Psoriatic
Mylan Inc. 294
Not applicableStudy completedNCT00799877
What this trial is testing

Chronic Plaque Psoriasis (Ps) Registry

Who this might be right for
Chronic Plaque Psoriasis
AbbVie 6,065
Next Page